choline has been researched along with Coronary Artery Disease in 15 studies
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the causal role of choline metabolites mediating sodium-glucose cotransporter 2 (SGLT2) inhibition in coronary artery disease (CAD) and type 2 diabetes (T2D) using Mendelian randomization (MR)." | 5.22 | SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study. ( Bi, Y; Hou, T; Li, M; Lin, H; Lu, J; Ning, G; Wang, S; Wang, T; Wang, W; Xu, M; Xu, Y; Zhao, Z; Zheng, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (53.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Amrein, M | 1 |
| Li, XS | 2 |
| Walter, J | 1 |
| Wang, Z | 2 |
| Zimmermann, T | 1 |
| Strebel, I | 1 |
| Honegger, U | 1 |
| Leu, K | 1 |
| Schäfer, I | 1 |
| Twerenbold, R | 1 |
| Puelacher, C | 1 |
| Glarner, N | 1 |
| Nestelberger, T | 1 |
| Koechlin, L | 1 |
| Ceresa, B | 1 |
| Haaf, P | 1 |
| Bakula, A | 1 |
| Zellweger, M | 1 |
| Hazen, SL | 2 |
| Mueller, C | 1 |
| Xu, M | 1 |
| Zheng, J | 1 |
| Hou, T | 1 |
| Lin, H | 1 |
| Wang, T | 1 |
| Wang, S | 1 |
| Lu, J | 1 |
| Zhao, Z | 1 |
| Li, M | 2 |
| Xu, Y | 1 |
| Ning, G | 1 |
| Bi, Y | 1 |
| Wang, W | 1 |
| Koay, YC | 1 |
| Chen, YC | 1 |
| Wali, JA | 1 |
| Luk, AWS | 1 |
| Doma, H | 1 |
| Reimark, R | 1 |
| Zaldivia, MTK | 1 |
| Habtom, HT | 1 |
| Franks, AE | 1 |
| Fusco-Allison, G | 1 |
| Yang, J | 1 |
| Holmes, A | 1 |
| Simpson, SJ | 1 |
| Peter, K | 1 |
| O'Sullivan, JF | 1 |
| Tang, WHW | 1 |
| Wu, Y | 1 |
| Khaw, KT | 1 |
| Wareham, NJ | 1 |
| Nieuwdorp, M | 1 |
| Boekholdt, SM | 1 |
| Srinivasa, S | 1 |
| Fitch, KV | 1 |
| Lo, J | 1 |
| Kadar, H | 1 |
| Knight, R | 1 |
| Wong, K | 1 |
| Abbara, S | 1 |
| Gauguier, D | 1 |
| Capeau, J | 1 |
| Boccara, F | 1 |
| Grinspoon, SK | 1 |
| Muller, O | 1 |
| Barbato, E | 1 |
| De Bruyne, B | 1 |
| Bartunek, J | 1 |
| GREENBERG, SU | 1 |
| BRUGER, M | 1 |
| SAVENKOV, PM | 1 |
| FAUDA, C | 1 |
| GRIGOLATO, V | 1 |
| CANDIANI, C | 1 |
| SINITSINA, TA | 1 |
| MORRISON, LM | 3 |
| GONZALES, WF | 2 |
| GONZALEZ, WF | 1 |
| Danne, O | 1 |
| Lueders, C | 1 |
| Storm, C | 1 |
| Frei, U | 1 |
| Möckel, M | 1 |
| Olszewski, AJ | 1 |
| Szostak, WB | 1 |
| Bialkowska, M | 1 |
| Rudnicki, S | 1 |
| McCully, KS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| BASEL VIII Trial - Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia[NCT01838148] | 4,000 participants (Anticipated) | Observational | 2004-05-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for choline and Coronary Artery Disease
| Article | Year |
|---|---|
SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study.
Topics: Choline; Coronary Artery Disease; Diabetes Mellitus, Type 2; Genome-Wide Association Study; Glycine; | 2022 |
Biomarkers of vulnerable plaque: the missing link with ischemia.
Topics: Albumins; Biomarkers; Choline; Coronary Artery Disease; Cystatin C; Fatty Acids, Nonesterified; Huma | 2010 |
13 other studies available for choline and Coronary Artery Disease
| Article | Year |
|---|---|
Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
Topics: Betaine; Cardiovascular Diseases; Carnitine; Choline; Coronary Artery Disease; Gastrointestinal Micr | 2022 |
Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.
Topics: Animal Feed; Animals; Atherosclerosis; Bacteria; Biomarkers; Carotid Artery Diseases; Choline; Coron | 2021 |
Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study.
Topics: Aged; Case-Control Studies; Choline; Coronary Artery Disease; Correlation of Data; Female; Gastroint | 2021 |
Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine.
Topics: Choline; Coronary Artery Disease; Dysbiosis; Female; HIV Infections; Humans; Intestinal Diseases; Ma | 2015 |
Failure of choline therapy to alter serum lipids in patients with coronary artery disease.
Topics: Anti-Arrhythmia Agents; Blood; Cardiotonic Agents; Choline; Coronary Artery Disease; Coronary Diseas | 1953 |
[The use of choline in coronary atherosclerosis].
Topics: Anti-Arrhythmia Agents; Cardiotonic Agents; Choline; Coronary Artery Disease; Coronary Disease; Glyc | 1957 |
[Association of coronarodilatory & cardiotrophic drugs in the treatment of coronary insufficiency].
Topics: Anti-Arrhythmia Agents; Choline; Coronary Artery Disease; Coronary Disease; Enzyme Inhibitors; Human | 1959 |
[Effect of choline and thyroxin on recurrent development of coronary atherosclerosis].
Topics: Arteriosclerosis; Choline; Coronary Artery Disease; Coronary Disease; Humans; Thyroxine | 1955 |
Effect of choline as a lipotropic agent in the treatment of human coronary atherosclerosis.
Topics: Arteriosclerosis; Choline; Coronary Artery Disease; Lipotropic Agents | 1950 |
Results of treatment in coronary arteriosclerosis with lipotropic agents.
Topics: Arteriolosclerosis; Arteriosclerosis; Choline; Coronary Artery Disease; Lipotropic Agents | 1950 |
Results of treatment of coronary arteriosclerosis with choline.
Topics: Choline; Coronary Artery Disease; Coronary Vessels; Humans | 1950 |
Whole blood choline and plasma choline in acute coronary syndromes: prognostic and pathophysiological implications.
Topics: Aged; Choline; Chromatography, High Pressure Liquid; Coronary Artery Disease; Coronary Disease; Fema | 2007 |
Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis.
Topics: Adult; Anticoagulants; Choline; Coronary Artery Disease; Coronary Disease; Drug Therapy, Combination | 1989 |